Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Precision Optics Corporation, Inc. Common stock (POCI)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/30/2025: POCI (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $
1 Year Target Price $
| 0 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -36.8% | Avg. Invested days 28 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/30/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 37.72M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.21 | 52 Weeks Range 3.47 - 6.59 | Updated Date 06/29/2025 |
52 Weeks Range 3.47 - 6.59 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.91 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -32.84% | Operating Margin (TTM) -48.69% |
Management Effectiveness
Return on Assets (TTM) -18.31% | Return on Equity (TTM) -47.37% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 36585163 | Price to Sales(TTM) 2.14 |
Enterprise Value 36585163 | Price to Sales(TTM) 2.14 | ||
Enterprise Value to Revenue 2.08 | Enterprise Value to EBITDA -27.04 | Shares Outstanding 7666250 | Shares Floating 5681226 |
Shares Outstanding 7666250 | Shares Floating 5681226 | ||
Percent Insiders 22.65 | Percent Institutions 31.47 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Precision Optics Corporation, Inc. Common stock
Company Overview
History and Background
Precision Optics Corporation, Inc. (POCI) was founded in 1982. They specialize in the design, development, and manufacture of advanced optical systems and components.
Core Business Areas
- Medical: Designing and manufacturing precision optical systems for minimally invasive surgical and diagnostic procedures. Focus on endoscopes and robotic surgery visualization systems.
- Defense: Providing ruggedized optical solutions for military applications including surveillance, targeting, and imaging systems.
- Industrial: Developing custom optical solutions for industrial metrology, inspection, and process control applications.
Leadership and Structure
The leadership team includes Joseph Forkey (CEO). The company is structured with departments for engineering, manufacturing, sales, and marketing.
Top Products and Market Share
Key Offerings
- Microlens Arrays: Microlens arrays for various applications. Market share data is not readily available, and competitors include Edmund Optics, Thorlabs.
- Endoscopic Imaging Systems: Optical systems for endoscopes used in medical procedures. Market share data is not publicly available, and competitors include Olympus, Stryker, Karl Storz.
Market Dynamics
Industry Overview
The precision optics industry is driven by increasing demand for advanced imaging and sensing technologies in healthcare, defense, and industrial sectors.
Positioning
POCI is a niche player focused on custom optical solutions. Its competitive advantage lies in its engineering expertise and ability to meet specific customer requirements.
Total Addressable Market (TAM)
The precision optics market is estimated to be in the tens of billions USD globally. POCI is positioned to capture a portion of this TAM through specialized applications.
Upturn SWOT Analysis
Strengths
- Engineering expertise
- Custom solutions
- Strong customer relationships
- Defense contracts
Weaknesses
- Limited scale
- Dependence on specific projects
- Vulnerable to global supply chain disruptions
- Thinly traded stock
Opportunities
- Expanding into new medical applications
- Growing defense spending
- Adoption of advanced imaging technologies
- Strategic partnerships
Threats
- Competition from larger players
- Technological obsolescence
- Economic downturns
- Geopolitical instability
Competitors and Market Share
Key Competitors
- LITE
- COHR
- IPGP
Competitive Landscape
POCI is a smaller player compared to larger, more established competitors. Specialization helps to offset lack of size.
Major Acquisitions
REFLEX Medical
- Year: 2018
- Acquisition Price (USD millions): 2
- Strategic Rationale: Acquisition of Reflex Medical to expand its capabilities in the medical device market.
Growth Trajectory and Initiatives
Historical Growth: Revenue growth has been erratic. POCI has been known to experience periods of growth and then slowdown.
Future Projections: Analyst estimates vary widely. Continued growth will rely heavily on securing projects and ongoing contracts.
Recent Initiatives: Seeking growth in defense sector and expansion of medical products.
Summary
Precision Optics Corporation is a small company specializing in custom optics for medical and defense applications. Revenue growth has been variable and the company has experienced periods of net losses. The company's size is a weakness that leaves it vulnerable to competition from larger competitors. POCI's prospects may improve if it continues to secure new contracts and is able to grow within the defense and medical device sectors.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings
- Analyst reports
- Industry databases
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Investment decisions should be based on independent research and consultation with a qualified financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Precision Optics Corporation, Inc. Common stock
Exchange NASDAQ | Headquaters Gardner, MA, United States | ||
IPO Launch date 1992-01-16 | CEO, President, Treasurer & Director Dr. Joseph N. Forkey | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 83 | Website https://www.poci.com |
Full time employees 83 | Website https://www.poci.com | ||
Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States. The company offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. It also provides components and assemblies for industrial and military use. It markets its products to medical device companies. Precision Optics Corporation, Inc. was incorporated in 1982 and is based in Gardner, Massachusetts.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.